WillisHollowayJr.MD

Clinical Trials

• Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex Start of enrollment: 2011 Jun 01

  Completed

  Phase 3

• PEARL Schizophrenia Maintenance Start of enrollment: 2011 Sep 01

  Completed

  Phase 3

• This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 Start of enrollment: 2012 Jun 01

  Completed

  Phase 3

• Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01

  Terminated

  Phase 3

• Pediatric Schizophrenia Efficacy and Safety Study Start of enrollment: 2013 Aug 01

  Completed

  Phase 3

• Lurasidone Pediatric Autism Study Start of enrollment: 2013 Aug 01

  Completed

  Phase 3

• Pediatric Open-Label Extension Study Start of enrollment: 2013 Sep 30

  Completed

  Phase 3

• Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy Start of enrollment: 2013 Nov 01

  Completed

  Phase 3

• Lurasidone Pediatric Bipolar Study Start of enrollment: 2014 Mar 01

  Completed

  Phase 3

• Open-label Safety Study in Adults With ADHD Start of enrollment: 2014 Jun 01

  Completed

  Phase 3

• Dasotraline SEP360-105 Pediatric PK/PD Study Start of enrollment: 2014 Jul 01

  Completed

  Phase 1

• Dasotraline Pediatric ADHD Study Start of enrollment: 2015 Apr 01

  Completed

  Phase 2, Phase 3

• Dasotraline Pediatric Extension Study Start of enrollment: 2015 Jun 30

  Completed

  Phase 3

• Join now to see all